Literature DB >> 2459411

A herpesvirus vector for expression of glycosylated membrane antigens: fusion proteins of pseudorabies virus gIII and human immunodeficiency virus type 1 envelope glycoproteins.

M E Whealy1, K Baumeister, A K Robbins, L W Enquist.   

Abstract

We describe experiments using the swine herpesvirus, pseudorabies virus (PRV), as a vector for expression of hybrid membrane protein genes. In particular, we present the construction and analysis of three infectious PRV mutants expressing chimeric viral membrane proteins composed of portions of the PRV envelope glycoprotein gIII and of the human retrovirus, human immunodeficiency virus type 1 (HIV-1), envelope glycoproteins gp120 and gp41. All of the chimeric genes contain the transcription control sequences and the first 157 codons of PRV gIII (known to contain signals sufficient for efficient export of the encoded peptide out of the cell) fused to different regions of the HIV-1 envelope. The mutant viruses express novel glycosylated fusion proteins that are immunoprecipitated by polyvalent sera specific for gIII, as well as acquired immunodeficiency syndrome patient sera. The levels of expression are lower than expected due primarily to instability or altered processing of the hybrid mRNA. We could not detect cleavage of chimeric proteins carrying the gp120-gp41 protease processing site. The use of localization signals contained within herpesvirus membrane proteins to direct chimeric proteins to desired cellular locations is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459411      PMCID: PMC253850     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

Review 3.  Genetic engineering of novel genomes of large DNA viruses.

Authors:  B Roizman; F J Jenkins
Journal:  Science       Date:  1985-09-20       Impact factor: 47.728

4.  Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex.

Authors:  N Lukàcs; H J Thiel; T C Mettenleiter; H J Rziha
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay.

Authors:  T C Holland; R M Sandri-Goldin; L E Holland; S D Marlin; M Levine; J C Glorioso
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

6.  Visualization of minute centers of viral infection in unfixed cell cultures by an enzyme-linked antibody assay.

Authors:  K O Smith; W L Kennell; D L Lamm
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

7.  Characterization of the envelope proteins of pseudorabies virus.

Authors:  H Hampl; T Ben-Porat; L Ehrlicher; K O Habermehl; A S Kaplan
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

9.  Pseudorabies virus glycoprotein gIII is required for efficient virus growth in tissue culture.

Authors:  M E Whealy; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway.

Authors:  M G Roth; C Doyle; J Sambrook; M J Gething
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  9 in total

1.  The export pathway of the pseudorabies virus gB homolog gII involves oligomer formation in the endoplasmic reticulum and protease processing in the Golgi apparatus.

Authors:  M E Whealy; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system.

Authors:  U A Gompels; A C Minson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins.

Authors:  G E Cole; S Stacy-Phipps; J H Nunberg
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress.

Authors:  M E Whealy; J P Card; R P Meade; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.

Authors:  M van Zijl; G Wensvoort; E de Kluyver; M Hulst; H van der Gulden; A Gielkens; A Berns; R Moormann
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Incorporation of CD4 into virions by a recombinant herpes simplex virus.

Authors:  K E Dolter; S R King; T C Holland
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Identification of the thymidine kinase gene of feline herpesvirus: use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homologs.

Authors:  J H Nunberg; D K Wright; G E Cole; E A Petrovskis; L E Post; T Compton; J H Gilbert
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  Expression of porcine pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector.

Authors:  S Kit; H Otsuka; M Kit
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants.

Authors:  A Rösen-Wolff; K Raab; L Zöller; G Darai; J Eberle; F Deinhardt
Journal:  Virus Genes       Date:  1990-12       Impact factor: 2.332

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.